Curtaz C, Harms J, Schmitt C, Sauer S, Christner S, Kessler A
    
    
    Cancers (Basel). 2025; 17(2).
  
  
    PMID: 39858042
    
          PMC: 11763549.
    
          DOI: 10.3390/cancers17020261.
      
 
                                  
  
    Niedermeyer S, Schmutzer-Sondergeld M, Weller J, Katzendobler S, Kirchleitner S, Forbrig R
    
    
    J Neurooncol. 2024; 169(2):349-358.
  
  
    PMID: 38904924
    
          PMC: 11341644.
    
          DOI: 10.1007/s11060-024-04744-w.
      
 
                                  
  
    Xu J, Gao F, Liu W, Guan X
    
    
    Cell Commun Signal. 2024; 22(1):55.
  
  
    PMID: 38243240
    
          PMC: 10799417.
    
          DOI: 10.1186/s12964-023-01418-4.
      
 
                                  
  
    Saltarin F, Wegmuller A, Bejarano L, Ildiz E, Zwicky P, Vianin A
    
    
    Cancers (Basel). 2023; 15(20).
  
  
    PMID: 37894438
    
          PMC: 10605101.
    
          DOI: 10.3390/cancers15205071.
      
 
                                  
  
    Andriani R, Rosewitasari J, Hanif M, Mulawarman A, Kurniawati S, Fachri A
    
    
    Clin Med Insights Oncol. 2023; 17:11795549231178172.
  
  
    PMID: 37359276
    
          PMC: 10285584.
    
          DOI: 10.1177/11795549231178172.
      
 
                              
              
                              
                                      
  Epidemiological trends, prognostic factors, and survival outcomes of synchronous brain metastases from 2015 to 2019: a population-based study.
  
    Parker M, Jiang K, Rincon-Torroella J, Materi J, Azad T, Kamson D
    
    
    Neurooncol Adv. 2023; 5(1):vdad015.
  
  
    PMID: 36968289
    
          PMC: 10034914.
    
          DOI: 10.1093/noajnl/vdad015.
      
 
                                          
                                                          
  Frequency of seizures in patients with metastatic brain tumors.
  
    Huntoon K, Musgrave N, Shaikhouni A, Elder J
    
    
    Neurol Sci. 2023; 44(7):2501-2507.
  
  
    PMID: 36808311
    
    
          DOI: 10.1007/s10072-023-06695-y.
      
 
                                          
                                                          
  Varied Clinical Presentation and Management of Calvarial Metastases.
  
    Gupta S, Sharma G, Sajeevan S, Raut S, Ahuja R, Joseph D
    
    
    Asian J Neurosurg. 2022; 17(4):631-634.
  
  
    PMID: 36570766
    
          PMC: 9771635.
    
          DOI: 10.1055/s-0042-1757626.
      
 
                                          
                                                          
  Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors.
  
    Matsui J, Perlow H, Raj R, Nalin A, Lehrer E, Kotecha R
    
    
    Biomedicines. 2022; 10(9).
  
  
    PMID: 36140312
    
          PMC: 9496359.
    
          DOI: 10.3390/biomedicines10092211.
      
 
                                          
                                                          
  Targeting CDK4 and 6 in Cancer Therapy: Emerging Preclinical Insights Related to Abemaciclib.
  
    Wander S, OBrien N, Litchfield L, ODea D, Morato Guimaraes C, Slamon D
    
    
    Oncologist. 2022; 27(10):811-821.
  
  
    PMID: 35917168
    
          PMC: 9526495.
    
          DOI: 10.1093/oncolo/oyac138.
      
 
                                          
                                                          
  Local and systemic therapy in breast cancer patients with central nervous system metastases.
  
    Wellerdieck N, Wessels P, Los M, Sonke G, Tromp E, Brandsma D
    
    
    Breast Cancer Res Treat. 2022; 194(2):365-384.
  
  
    PMID: 35680734
    
    
          DOI: 10.1007/s10549-022-06605-4.
      
 
                                          
                                                          
  Analysis of microRNAs in Exosomes of Breast Cancer Patients in Search of Molecular Prognostic Factors in Brain Metastases.
  
    Curtaz C, Reifschlager L, Strahle L, Feldheim J, Feldheim J, Schmitt C
    
    
    Int J Mol Sci. 2022; 23(7).
  
  
    PMID: 35409043
    
          PMC: 8999078.
    
          DOI: 10.3390/ijms23073683.
      
 
                                          
                                                          
  Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors.
  
    Demetri G, De Braud F, Drilon A, Siena S, Patel M, Cho B
    
    
    Clin Cancer Res. 2022; 28(7):1302-1312.
  
  
    PMID: 35144967
    
          PMC: 9365368.
    
          DOI: 10.1158/1078-0432.CCR-21-3597.
      
 
                                          
                                                          
  Volumetric Response of Limited Brain Metastatic Disease to Focal Hypofractionated Radiation Therapy.
  
    Wijetunga A, Jayamanne D, Adams J, Back M
    
    
    Brain Sci. 2021; 11(11).
  
  
    PMID: 34827456
    
          PMC: 8615909.
    
          DOI: 10.3390/brainsci11111457.
      
 
                                          
                                                          
  Neoplastic cerebral aneurysm from triple-negative breast cancer: A case report.
  
    Nussbaum E, Torok C, Khalil Z, Pederson J
    
    
    Surg Neurol Int. 2021; 12:204.
  
  
    PMID: 34084631
    
          PMC: 8168699.
    
          DOI: 10.25259/SNI_74_2021.
      
 
                                          
                                                          
  Epidemiology of brain metastases and leptomeningeal disease.
  
    Lamba N, Wen P, Aizer A
    
    
    Neuro Oncol. 2021; 23(9):1447-1456.
  
  
    PMID: 33908612
    
          PMC: 8408881.
    
          DOI: 10.1093/neuonc/noab101.
      
 
                                          
                                                          
  Multifocal glioblastoma-two case reports and literature review.
  
    Zhang Z, Chen J, Shi B, Li G, Li Y, Xiang Y
    
    
    Chin Neurosurg J. 2021; 7(1):8.
  
  
    PMID: 33446281
    
          PMC: 7809824.
    
          DOI: 10.1186/s41016-020-00223-z.
      
 
                                          
                                                          
  Endocrine therapy for the treatment of leptomeningeal carcinomatosis in luminal breast cancer: a comprehensive review.
  
    Fernandes L, Vasconcelos de Matos L, Cardoso D, Saraiva M, Medeiros-Mirra R, Coelho A
    
    
    CNS Oncol. 2020; 9(4):CNS65.
  
  
    PMID: 33078616
    
          PMC: 7737195.
    
          DOI: 10.2217/cns-2020-0023.
      
 
                                          
                                                          
  Alterations of functional and structural connectivity in patients with brain metastases.
  
    Hua B, Ding X, Xiong M, Zhang F, Luo Y, Ding J
    
    
    PLoS One. 2020; 15(5):e0233833.
  
  
    PMID: 32470024
    
          PMC: 7259727.
    
          DOI: 10.1371/journal.pone.0233833.
      
 
                                          
                                                          
  Serum-derived factors of breast cancer patients with brain metastases alter permeability of a human blood-brain barrier model.
  
    Curtaz C, Schmitt C, Herbert S, Feldheim J, Schlegel N, Gosselet F
    
    
    Fluids Barriers CNS. 2020; 17(1):31.
  
  
    PMID: 32321535
    
          PMC: 7178982.
    
          DOI: 10.1186/s12987-020-00192-6.